Literature DB >> 32516423

Methotrexate-induced Primary Cutaneous Diffuse Large B-cell Lymphoma in Patients with Erythrodermic Cutaneous T-cell Lymphoma.

Jérémie Delaleu1, Eve Maubec, Francois Rodrigues, Annie Lévy, Vanessa Szablewski, Lilliane Laroche, Olivier Dereure.   

Abstract

is missing (Short communication).

Entities:  

Keywords:  B-cell lymphoma; Epstein barr virus ; T cell lymphoma; methotrexate

Mesh：

Substances：

Year:  2020        PMID： 32516423      PMCID： PMC9207630          DOI： 10.2340/00015555-3554

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


  14 in total

1.  Treatment of advanced stage methotrexate-associated lymphoproliferative disorders (MTX-LPDs) with methotrexate discontinuation.

Authors:  Yael Ross; Mohammad Kamran
Journal:  BMJ Case Rep       Date:  2018-12-13

2.  Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.

Authors:  Jonathan L Curry; Victor G Prieto; Dan M Jones; Franscisco Vega; Madeleine Duvic; A Hafeez Diwan
Journal:  J Cutan Pathol       Date:  2011-03       Impact factor: 1.587

Review 3.  Cutaneous manifestations of methotrexate-associated lymphoproliferative disorders: report of two cases and a review of the literature.

Authors:  Satoko Shimizu; Daisuke Inokuma; Junko Murata; Kazuhiro Kikuchi; Takamasa Ito; Yuichiro Fukasawa; Masaya Mukai; Reine Moriuchi
Journal:  Acta Derm Venereol       Date:  2015-03       Impact factor: 4.437

4.  Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a patient with Sézary syndrome treated by methotrexate.

Authors:  S Ingen-Housz-Oro; N Ortonne; N Cordel; J Moroch; G Do-Pham; M H Delfau; C Haioun; O Chosidow
Journal:  Br J Dermatol       Date:  2016-06-20       Impact factor: 9.302

5.  A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.

Authors:  Noriyuki Yamakawa; Masakazu Fujimoto; Daisuke Kawabata; Chikashi Terao; Momoko Nishikori; Ran Nakashima; Yoshitaka Imura; Naoichiro Yukawa; Hajime Yoshifuji; Koichiro Ohmura; Takao Fujii; Toshiyuki Kitano; Tadakazu Kondo; Kimiko Yurugi; Yasuo Miura; Taira Maekawa; Hiroh Saji; Akifumi Takaori-Kondo; Fumihiko Matsuda; Hironori Haga; Tsuneyo Mimori
Journal:  J Rheumatol       Date:  2013-12-15       Impact factor: 4.666

6.  Methotrexate-Associated B-Cell Lymphoproliferative Disease in a Patient With Cutaneous T-Cell Lymphoma.

Authors:  Andrea D Maderal; Janine C Malone; Jeffrey P Callen
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

7.  Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

Authors:  Xavier Mariette; Dominique Cazals-Hatem; Josiane Warszawki; Frédéric Liote; Nathalie Balandraud; Jean Sibilia
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

8.  EBV+ cutaneous B-cell lymphoproliferation of the leg in an elderly patient with mycosis fungoides and methotrexate treatment.

Authors:  Thierry Rausch; Anne Cairoli; Jean Benhattar; Philipp Spring; Daniel Hohl; Laurence de Leval
Journal:  APMIS       Date:  2012-07-03       Impact factor: 3.205

9.  Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.

Authors:  Lianne Koens; Nancy J Senff; Maarten H Vermeer; Rein Willemze; Patty M Jansen
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

10.  Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.

Authors:  Michihide Tokuhira; Jun-Ichi Tamaru; Masahiro Kizaki
Journal:  J Clin Exp Hematop       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.